Reply.
作者信息
Shakhnovich Valentina, Smith P Brian, Wu Huali, Cohen-Wolkowiez Michael, Kearns Gregory L
机构信息
Division of Gastroenterology, Hepatology and Nutrition Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation The Children's Mercy Hospital Kansas City, Missouri.
Department of Pediatrics Division of Neonatal-Perinatal Medicine Duke Clinical Research Institute Durham, North Carolina.
出版信息
J Pediatr. 2018 Jul;198:327-328. doi: 10.1016/j.jpeds.2018.03.001. Epub 2018 Apr 18.
Abstract
摘要
相似文献
1
Reply.回复。
J Pediatr. 2018 Jul;198:327-328. doi: 10.1016/j.jpeds.2018.03.001. Epub 2018 Apr 18.
2
Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity.瘦体重给药可避免肥胖儿童对质子泵抑制剂产生过度的全身暴露。
Pediatr Obes. 2019 Jan;14(1). doi: 10.1111/ijpo.12459. Epub 2018 Sep 26.
3
Pantoprazole pharmacokinetics in obese children: normalized to lean or ideal weight?泮托拉唑在肥胖儿童中的药代动力学：按瘦体重还是理想体重进行标准化？
J Pediatr. 2018 Jul;198:327. doi: 10.1016/j.jpeds.2018.02.066. Epub 2018 Apr 19.
4
Pantoprazole in Patients in the ICU. Reply.重症监护病房患者使用泮托拉唑。回复。
N Engl J Med. 2019 Mar 7;380(10):985. doi: 10.1056/NEJMc1900206.
5
Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B.双倍剂量泮托拉唑可加速超重和肥胖的洛杉矶 A 和 B 级反流性食管炎患者的持续症状缓解。
Am J Gastroenterol. 2010 May;105(5):1046-52. doi: 10.1038/ajg.2009.632. Epub 2009 Nov 10.
6
Pharmacokinetics of pantoprazole in patients with moderate and severe hepatic dysfunction.泮托拉唑在中重度肝功能不全患者中的药代动力学。
Clin Ther. 2001 Aug;23(8):1180-92. doi: 10.1016/s0149-2918(01)80100-4.
7
Pantoprazole blocks the JAK2/STAT3 pathway to alleviate skeletal muscle wasting in cancer cachexia by inhibiting inflammatory response.泮托拉唑通过抑制炎症反应阻断JAK2/STAT3通路，以减轻癌症恶病质中的骨骼肌消耗。
Oncotarget. 2017 Jun 13;8(24):39640-39648. doi: 10.18632/oncotarget.17387.
8
Reply.回复。
Gastroenterology. 2020 Jan;158(1):285-286. doi: 10.1053/j.gastro.2019.10.032. Epub 2019 Nov 5.
9
Pantoprazole, an Inhibitor of the Organic Cation Transporter 2, Does Not Ameliorate Cisplatin-Related Ototoxicity or Nephrotoxicity in Children and Adolescents with Newly Diagnosed Osteosarcoma Treated with Methotrexate, Doxorubicin, and Cisplatin.泮托拉唑，一种有机阳离子转运体 2 抑制剂，不能改善新诊断的骨肉瘤患儿和青少年接受甲氨蝶呤、多柔比星和顺铂治疗后的顺铂相关耳毒性或肾毒性。
Oncologist. 2018 Jul;23(7):762-e79. doi: 10.1634/theoncologist.2018-0037. Epub 2018 Feb 14.
10
Lack of pharmacokinetic interaction of pantoprazole with diazepam in man.泮托拉唑与人地西泮之间不存在药代动力学相互作用。
Br J Clin Pharmacol. 1996 Aug;42(2):249-52. doi: 10.1046/j.1365-2125.1996.40619.x.
本文引用的文献
1
Obese Children Require Lower Doses of Pantoprazole Than Nonobese Peers to Achieve Equal Systemic Drug Exposures.肥胖儿童达到同等系统药物暴露所需的泮托拉唑剂量低于非肥胖同龄人。
J Pediatr. 2018 Feb;193:102-108.e1. doi: 10.1016/j.jpeds.2017.10.011.
2
A multicenter, randomized, open-label, pharmacokinetics and safety study of pantoprazole tablets in children and adolescents aged 6 through 16 years with gastroesophageal reflux disease.一项多中心、随机、开放标签、药代动力学和安全性研究，评估泮托拉唑片在 6 至 16 岁患有胃食管反流病的儿童和青少年中的应用。
J Clin Pharmacol. 2011 Jun;51(6):876-87. doi: 10.1177/0091270010377501. Epub 2010 Sep 17.
Zotero 插件